Bayesian Capital Management, LP Davita Inc. Transaction History

Bayesian Capital Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$103.89 - $139.21 $93,501 - $125,289	-900 Reduced 5.59%	15,189 $2.1 Million
Q3 2023 Nov 14, 2023	BUY	$94.53 - $112.68 $538,821 - $642,276	5,700 Added 54.87%	16,089 $1.52 Million
Q2 2023 Aug 14, 2023	BUY	$81.58 - $100.93 $847,534 - $1.05 Million	10,389 New	10,389 $1.04 Million
Q2 2022 Aug 15, 2022	SELL	$76.05 - $123.38 $402,076 - $652,310	-5,287 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$108.37 - $120.0 $572,952 - $634,440	5,287 New	5,287 $598,000
Q4 2020 Feb 12, 2021	SELL	$82.82 - $117.4 $431,409 - $611,536	-5,209 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$79.57 - $91.84 $275,073 - $317,490	-3,457 Reduced 39.89%	5,209 $446,000
Q2 2020 Aug 14, 2020	SELL	$65.52 - $88.28 $609,336 - $821,004	-9,300 Reduced 51.76%	8,666 $686,000
Q1 2020 May 15, 2020	BUY	$64.99 - $88.5 $277,247 - $377,541	4,266 Added 31.14%	17,966 $1.37 Million
Q4 2019 Feb 14, 2020	BUY	$54.2 - $75.03 $742,540 - $1.03 Million	13,700 New	13,700 $1.03 Million

618

76.1M

1.16M

760K

Ticker DVA
Exchange NYSE
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 91,300,000
Market Cap $15B
Description
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.